On Jul. 6, 2020, the FDA issued an emergency use authorization (EUA) for the third diagnostic test for…
On Jul. 6, 2020, the lack of universal recognition that COVID-19 is transmitted via airborne particles, along with…
On Jul. 6, 2020, Sinovac Biotech announced that on Jul. 3, 2020, the Brazilian National Regulatory Agency, Anvisa,…
On Jul. 9, 2020, Altimmune announced that it had entered into a teaming agreement with DynPort Vaccine Company…
On Jul. 3, 2020, Gilead Sciences announced the European Commission had granted conditional marketing authorization for Vekluryﾮ (remdesivir)…
On Jul. 2, 2020, Abivax announced that the first patient has been treated in its Phase 2b/3 study…
On Jul. 2, 2020, in response to the continuing need for more COVID-19 diagnostic tests, the Translational Genomics…
On Jul. 2, 2020, Maxim Biomedical announced plans to produce and market as many as 3 million Maxim…
On Jul. 2, 2020, ViiV Healthcare, a GSK company, with Pfizer and Shionogi Limited, announced the FDA had…
On Jul. 1, 2020, MediciNova announced that the Investigational New Drug Application (IND) for MN-166 (ibudilast) for prevention…
On Jul. 1, 2020, Merck and and and Ridgeback Biotherapeutics announced that the U.S. Federal Trade Commission (FTC)…
On Jul. 1, 2020, T2 Biosystems announced completion of validation of its COVID-19 molecular diagnostic test, the T2SARS-CoV-2…
On Jul. 1, 2020, OPKO Health announced the results of COVID-19 molecular PCR and antibody tests for nursing…
On Jul. 1, 2020, Pfizer and BioNTech announced preliminary data from the most advanced of four investigational vaccine…
On Jul. 1, 2020, in a Perspective for the New England Journal of Medicine, members of the NIHﾒs…
On Jun. 30, 2020, scientists from the Innovative Genomics Institute (IGI) at the University of California Berkeley announced…
On Jun. 29, 2020, Gilead Sciences announced that the Covid-19 drug Remdesivir will cost $3,120 for typical patient…
On Jun. 29, 2020, the University of Oxford reported that potential COVID-19 hotspots can be identified using a…
On Jun. 29, 2020, JAMA reported that U.S. populationﾖbased time series analysis conducted between March 9, 2020, and…
On Jun. 29, 2020, Altimmune announced it was awarded $4.7 million from the U.S. Army Medical Research &…
On Jun. 29, 2020, LabCorpﾮ announced that Covance, its drug development business, has deployed the Xcellerateﾮ COVID-19 solution…
On Jun. 26, 2020, more than 300 scientists and clinicians from the federal government, industry and academia published…
On Jun. 26, 2020, Vaxart announced that its oral COVID-19 vaccine had been selected to participate in a…
On Jun. 25, 2020, Vaxart announced it had signed a Memorandum of Understanding with Attwill Medical Solutions Sterilflow,…
On Jun. 25, 2020, LabCorpﾮ announced the launch of a new test that can be used to assess…
On Jun. 24, 2020, HHMI investigators reported that data from COVID-19 cases around the world suggest that the…
On Jun. 24, 2020, Symbiosis Pharmaceutical Services, an India-based specialist provider of pharmaceutical and vaccine development services, announced…
On Jun. 24, 2020, the University of Oxford that the COVID-19 National DiagnOstic Research and Evaluation Platform (CONDOR)…
On Jun. 24, 2020, iBio announced that IBM Watson Health has selected iBio to receive 18 months of…
On Jun. 24, 2020, a team of scientists at Texas A&M University announced it is working with iBio…